JMP Securities Maintains Market Outperform on Dynavax Technologies, Lowers Price Target to $31

Benzinga · 5d ago
JMP Securities analyst Roy Buchanan maintains Dynavax Technologies (NASDAQ:DVAX) with a Market Outperform and lowers the price target from $33 to $31.